Radiation-inducible silencing of uPA and uPAR in vitro and in vivo in meningioma
- PMID: 20198323
- PMCID: PMC2837517
- DOI: 10.3892/ijo_00000557
Radiation-inducible silencing of uPA and uPAR in vitro and in vivo in meningioma
Abstract
Stereospecific radiation treatment offers a distinct opportunity for temporal and spatial regulation of gene expression at tumor sites by means of inducible promoters. To this end, a plasmid, pCArG-U2, was constructed by incorporating nine CArG elements (in tandem) of EGR1 gene upstream to uPA and uPAR siRNA oligonucleotides in a pCi-neo vector. Radiation-induced siRNA expression was detected in a meningioma cell line (IOMM-Lee). Immunoblotting and RT-PCR analyses confirmed downregulation of uPA and uPAR. A similar effect was observed in transfected cells followed by H2O2 treatment. Moreover, pre-treatment of transfected cells with N-acetyl L-cysteine blocked the silencing of uPA and uPAR, which further confirmed the oxidative damage-mediated downregulation. Cell proliferation assays and Western blot analysis for apoptotic molecules confirmed cell death in a radiation-inducible fashion. Migration and matrigel invasion assays also revealed a marked decrease in migration and invasion. Immunocytochemistry showed a marked decrease in uPA and uPAR levels in transfected and irradiated cells. H&E staining revealed a decrease in the pre-established tumor volume among the animals treated with pCArG-U2 and radiation. Immunohistochemistry of the brain sections established with intracranial tumors also revealed a marked decrease in uPA and uPAR in a radiation-inducible fashion. Taken together, our data suggest pCArG-U2 as a suitable candidate for radiation-inducible gene therapy.
Figures





Similar articles
-
uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.Int J Oncol. 2008 Nov;33(5):937-47. Int J Oncol. 2008. PMID: 18949356 Free PMC article.
-
RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth.Int J Oncol. 2006 Jun;28(6):1353-60. Int J Oncol. 2006. PMID: 16685436 Free PMC article.
-
Oncogenic role of p53 is suppressed by si-RNA bicistronic construct of uPA, uPAR and cathepsin-B in meningiomas both in vitro and in vivo.Int J Oncol. 2011 Apr;38(4):973-83. doi: 10.3892/ijo.2011.934. Epub 2011 Feb 2. Int J Oncol. 2011. Retraction in: Int J Oncol. 2021 Apr;58(4):6. doi: 10.3892/ijo.2021.5186. PMID: 21290090 Free PMC article. Retracted.
-
uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.Oncotarget. 2016 Aug 30;7(35):57351-57366. doi: 10.18632/oncotarget.10344. Oncotarget. 2016. PMID: 27385000 Free PMC article. Review.
-
Therapeutic potential of siRNA-mediated targeting of urokinase plasminogen activator, its receptor, and matrix metalloproteinases.Methods Mol Biol. 2009;487:267-81. doi: 10.1007/978-1-60327-547-7_13. Methods Mol Biol. 2009. PMID: 19301652 Free PMC article. Review.
Cited by
-
Meningioma animal models: a systematic review and meta-analysis.J Transl Med. 2023 Oct 28;21(1):764. doi: 10.1186/s12967-023-04620-7. J Transl Med. 2023. PMID: 37898750 Free PMC article.
-
Is DNA Methylation a Ray of Sunshine in Predicting Meningioma Prognosis?Front Oncol. 2020 Sep 4;10:1323. doi: 10.3389/fonc.2020.01323. eCollection 2020. Front Oncol. 2020. PMID: 33014773 Free PMC article.
-
New Insight on the Role of Plasminogen Receptor in Cancer Progression.Cancer Growth Metastasis. 2015 Jul 29;8:35-42. doi: 10.4137/CGM.S27335. eCollection 2015. Cancer Growth Metastasis. 2015. PMID: 26279629 Free PMC article. Review.
-
Chk2-mediated G2/M cell cycle arrest maintains radiation resistance in malignant meningioma cells.Cancer Lett. 2011 Dec 26;313(1):64-75. doi: 10.1016/j.canlet.2011.08.022. Epub 2011 Sep 6. Cancer Lett. 2011. PMID: 21945852 Free PMC article.
-
α3β1 integrin promotes radiation-induced migration of meningioma cells.Int J Oncol. 2011 Jun;38(6):1615-24. doi: 10.3892/ijo.2011.987. Epub 2011 Mar 29. Int J Oncol. 2011. Retraction in: Int J Oncol. 2021 Apr;58(4):8. doi: 10.3892/ijo.2021.5189. PMID: 21455571 Free PMC article. Retracted.
References
-
- Park CM, Park MJ, Kwak HJ, Lee HC, Kim MS, Lee SH, Park IC, Rhee CH, Hong SI. Ionizing Radiation Enhances Matrix Metalloproteinase-2 Secretion and Invasion of Glioma Cells through Src/Epidermal Growth Factor Receptor-Mediated p38/Akt and Phosphatidylinositol 3-Kinase/Akt Signaling Pathways. Cancer Res. 2006;66:8511–8519. - PubMed
-
- Zhai GG, Malhotra R, Delaney M, Latham D, Nestler U, Zhang M, Mukherjee N, Song Q, Robe P, Chakravarti A. Radiation enhances the invasive potential of primary glioblastoma cells via activation of the Rho signaling pathway. J Neurooncol. 2006;76:227–237. - PubMed
-
- Scott SD, Marples B, Hendry JH, Lashford LS, Embleton MJ, Hunter RD, Howell A, Margison GP. A radiation-controlled molecular switch for use in gene therapy of cancer. Gene Ther. 2000;7:1121–1125. - PubMed
-
- Worthington J, McCarthy HO, Barrett E, Adams C, Robson T, Hirst DG. Use of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatment. J Gene Med. 2004;6:673–680. - PubMed
-
- Marignol L, Coffey M, Hollywood D, Lawler M. Radiation to control transgene expression in tumors. Cancer Biol Ther. 2007;6:1005–1012. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous